The Uric Acid Crystal Receptor Clec12A Potentiates Type I Interferon Responses

Proceedings of the National Academy of Sciences of the United States of America - United States
doi 10.1073/pnas.1821351116
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Proceedings of the National Academy of Sciences

Related search

Type I Interferon Receptor (IFN Receptor)

Science-Business eXchange
2014English

Mice Lacking the Type I Interferon Receptor Are Resistant toListeria Monocytogenes

Journal of Experimental Medicine
MedicineAllergyImmunology
2004English

Localization of Type I Interferon Receptor Limits Interferon-Induced TLR3 in Epithelial Cells

Journal of Interferon and Cytokine Research
MedicineVirologyImmunologyCell Biology
2009English

Deficiency of the Type I Interferon Receptor Protects Mice From Experimental Lupus

Arthritis & Rheumatism
2007English

Vein Graft Disease Is Prevented by Toll-Like Receptor 3 via Type-I Interferon Induced Decrease of Inflammatory Responses

European Journal of Vascular and Endovascular Surgery
SurgeryCardiovascular MedicineCardiology
2018English

Serum Uric Acid in Type 2 Diabetics

Annals of the College of Medicine, Mosul
2008English

Selective Packaging in Murine Coronavirus Promotes Virulence by Limiting Type I Interferon Responses

mBio
VirologyMicrobiology
2018English

The Benzodiazepine Diazepam Potentiates Responses of Α1β2γ2L Γ-Aminobutyric Acid Type a Receptors Activated by Either Γ-Aminobutyric Acid or Allosteric Agonists

Anesthesiology
AnesthesiologyPain Medicine
2013English

Regulatory NLRs Control the RLR-Mediated Type I Interferon and Inflammatory Responses in Human Dendritic Cells

Frontiers in Immunology
AllergyImmunology
2018English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy